Patent · US Active

Secreted proteins

US9914921B2 · kind B2 · utility

0Cited by

21References

9Claims

0Family size

Assignee

Incyte Corporation · US

Inventors

Henry Yue · Sunnyvale, US
Monique Yao · Mountain View, US
Ameena Gandhi · San Francisco, US
Mariah Baughn · San Jose, US
Anita Swarnakar · San Francisco, US
Narinder Walia · Merced, US
Madhusudan Sanjanwala · Los Altos, US
Michael Thorton · Oakland, US
Vicki S. Kaulback · Brentwood, US
Yan Lu · Mountain View, US
Kimberly Gietzen · San Diego, US
Neil Burford · Durham, US
Li Ding · Creve Coeur, US
April Hafalia · Pacifica, US
Y. Tang · Sunnyvale, US
Olga Bandman · Mountain View, US
Bridget Warren · Cupertino, US
Cynthia Honchell · Redwood City, US
Dyung Lu · San Jose, US
Kavitha Thangaveln · Santa Clara, US
Sally Lee · San Francisco, US
Yuming Xu · Mountain View, US
Junming Yang · San Jose, US
Preeti Lal · Sunnyvale, US
Bao Tran · Santa Clara, US
Craig Ison · San Jose, US
Brendan Duggan · Sunnyvale, US
Stephanie Kareht · San Jose, US

Key dates

Filing date	Dec 23, 2016
Grant date	Mar 13, 2018
Priority date	—
Expiry date	Dec 23, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.